Singapore, Jul 1, 2009: Rockwell Medical Technologies, a biopharmaceutical company offering products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, has appointed Dr Ajay Gupta as its Chief Scientific Officer (CSO). Dr Gupta will be responsible for the identification and development of new drug opportunities in the areas of women's health, oncology and parenteral nutrition based on the Soluble Ferric Pyrophosphate (SFP) platform, as well as new drugs for other targeted renal therapies and indications.

According to the company, Dr Gupta will continue to play an integral role in the development and commercialization of the company's lead drug SFP, indicated for the treatment of iron deficiency anemia in hemodialysis patients.

Dr Gupta, who is the Founder and Chairman of the Indian Society for Bone and Mineral Research, earned his MBBS degree and completed his residency in Internal Medicine from All India Institute of Medical Sciences (AIIMS), New Delhi, India. Dr Gupta is the inventor of dialysate iron therapy using SFP and is also the inventor of intravenous (IV) iron therapy using slow continuous infusion of SFP, including as an adjunct to parenteral nutritional admixtures. He has filed a number of patents in the areas of drugs, medical devices and diagnostic tests.